DOE PAGES title logo U.S. Department of Energy
Office of Scientific and Technical Information

Title: Further Characterization of the Capsule-Like Complex (CLC) Produced by Francisella tularensis Subspecies tularensis: Protective Efficacy and Similarity to Outer Membrane Vesicles

Abstract

Francisella tularensis is the etiologic agent of tularemia, and subspecies tularensis (type A) is the most virulent subspecies. The live vaccine strain (LVS) of subspecies holarctica produces a capsule-like complex (CLC) that consists of a large variety of glycoproteins. Expression of the CLC is greatly enhanced when the bacteria are subcultured in and grown on chemically defined medium. Deletion of two genes responsible for CLC glycosylation in LVS results in an attenuated mutant that is protective against respiratory tularemia in a mouse model. We sought to further characterize the CLC composition and to determine if a type A CLC glycosylation mutant would be attenuated in mice. The CLCs isolated from LVS extracted with 0.5% phenol or 1 M urea were similar, as determined by gel electrophoresis and Western blotting, but the CLC extracted with urea was more water-soluble. The CLC extracted with either 0.5% phenol or 1 M urea from type A strains was also similar to the CLC of LVS in antigenic properties, electrophoretic profile, and by transmission electron microscopy (TEM). The solubility of the CLC could be further enhanced by fractionation with Triton X-114 followed by N-Lauroylsarcosine detergents; the largest (>250 kDa) molecular size component appeared to bemore » an aggregate of smaller components. Outer membrane vesicles/tubules (OMV/T) isolated by differential centrifugation and micro-filtration appeared similar to the CLC by TEM, and many of the proteins present in the OMV/T were also identified in soluble and insoluble fractions of the CLC. Further investigation is warranted to assess the relationship between OMV/T and the CLC. The CLC conjugated to keyhole limpet hemocyanin or flagellin was highly protective against high-dose LVS intradermal challenge and partially protective against intranasal challenge. A protective response was associated with a significant rise in cytokines IL-12, IL-10, and IFN-γ. However, a type A CLC glycosylation mutant remained virulent in BALB/c mice, and immunization with the CLC did not protect mice against high dose respiratory challenge with type A strain SCHU S4.« less

Authors:
; ; ; ; ;
Publication Date:
Research Org.:
Univ. of Georgia, Athens, GA (United States)
Sponsoring Org.:
USDOE
OSTI Identifier:
1454329
Alternate Identifier(s):
OSTI ID: 1510308
Grant/Contract Number:  
FG02-93ER20097
Resource Type:
Published Article
Journal Name:
Frontiers in Cellular and Infection Microbiology
Additional Journal Information:
Journal Name: Frontiers in Cellular and Infection Microbiology Journal Volume: 8; Journal ID: ISSN 2235-2988
Publisher:
Frontiers Research Foundation
Country of Publication:
Switzerland
Language:
English
Subject:
59 BASIC BIOLOGICAL SCIENCES; Francisella tularensis; virulence factors; capsule-like complex; outer membrane vesicles; protection; immune response

Citation Formats

Champion, Anna E., Bandara, Aloka B., Mohapatra, Nrusingh, Fulton, Kelly M., Twine, Susan M., and Inzana, Thomas J. Further Characterization of the Capsule-Like Complex (CLC) Produced by Francisella tularensis Subspecies tularensis: Protective Efficacy and Similarity to Outer Membrane Vesicles. Switzerland: N. p., 2018. Web. doi:10.3389/fcimb.2018.00182.
Champion, Anna E., Bandara, Aloka B., Mohapatra, Nrusingh, Fulton, Kelly M., Twine, Susan M., & Inzana, Thomas J. Further Characterization of the Capsule-Like Complex (CLC) Produced by Francisella tularensis Subspecies tularensis: Protective Efficacy and Similarity to Outer Membrane Vesicles. Switzerland. https://doi.org/10.3389/fcimb.2018.00182
Champion, Anna E., Bandara, Aloka B., Mohapatra, Nrusingh, Fulton, Kelly M., Twine, Susan M., and Inzana, Thomas J. Fri . "Further Characterization of the Capsule-Like Complex (CLC) Produced by Francisella tularensis Subspecies tularensis: Protective Efficacy and Similarity to Outer Membrane Vesicles". Switzerland. https://doi.org/10.3389/fcimb.2018.00182.
@article{osti_1454329,
title = {Further Characterization of the Capsule-Like Complex (CLC) Produced by Francisella tularensis Subspecies tularensis: Protective Efficacy and Similarity to Outer Membrane Vesicles},
author = {Champion, Anna E. and Bandara, Aloka B. and Mohapatra, Nrusingh and Fulton, Kelly M. and Twine, Susan M. and Inzana, Thomas J.},
abstractNote = {Francisella tularensis is the etiologic agent of tularemia, and subspecies tularensis (type A) is the most virulent subspecies. The live vaccine strain (LVS) of subspecies holarctica produces a capsule-like complex (CLC) that consists of a large variety of glycoproteins. Expression of the CLC is greatly enhanced when the bacteria are subcultured in and grown on chemically defined medium. Deletion of two genes responsible for CLC glycosylation in LVS results in an attenuated mutant that is protective against respiratory tularemia in a mouse model. We sought to further characterize the CLC composition and to determine if a type A CLC glycosylation mutant would be attenuated in mice. The CLCs isolated from LVS extracted with 0.5% phenol or 1 M urea were similar, as determined by gel electrophoresis and Western blotting, but the CLC extracted with urea was more water-soluble. The CLC extracted with either 0.5% phenol or 1 M urea from type A strains was also similar to the CLC of LVS in antigenic properties, electrophoretic profile, and by transmission electron microscopy (TEM). The solubility of the CLC could be further enhanced by fractionation with Triton X-114 followed by N-Lauroylsarcosine detergents; the largest (>250 kDa) molecular size component appeared to be an aggregate of smaller components. Outer membrane vesicles/tubules (OMV/T) isolated by differential centrifugation and micro-filtration appeared similar to the CLC by TEM, and many of the proteins present in the OMV/T were also identified in soluble and insoluble fractions of the CLC. Further investigation is warranted to assess the relationship between OMV/T and the CLC. The CLC conjugated to keyhole limpet hemocyanin or flagellin was highly protective against high-dose LVS intradermal challenge and partially protective against intranasal challenge. A protective response was associated with a significant rise in cytokines IL-12, IL-10, and IFN-γ. However, a type A CLC glycosylation mutant remained virulent in BALB/c mice, and immunization with the CLC did not protect mice against high dose respiratory challenge with type A strain SCHU S4.},
doi = {10.3389/fcimb.2018.00182},
journal = {Frontiers in Cellular and Infection Microbiology},
number = ,
volume = 8,
place = {Switzerland},
year = {Fri Jun 15 00:00:00 EDT 2018},
month = {Fri Jun 15 00:00:00 EDT 2018}
}

Journal Article:
Free Publicly Available Full Text
Publisher's Version of Record
https://doi.org/10.3389/fcimb.2018.00182

Citation Metrics:
Cited by: 4 works
Citation information provided by
Web of Science

Save / Share:

Works referenced in this record:

A Defined O-Antigen Polysaccharide Mutant of Francisella tularensis Live Vaccine Strain Has Attenuated Virulence while Retaining Its Protective Capacity
journal, February 2007

  • Sebastian, S.; Dillon, S. T.; Lynch, J. G.
  • Infection and Immunity, Vol. 75, Issue 5
  • DOI: 10.1128/IAI.01789-06

Electrochemical Modification of a Graphite Platform for a Solid Sampling Electrothermal Atomic Absorption Spectrometry of Mercury
journal, January 2010

  • Cervenka, Rostislav; ZelinkovÁ, Hana; KonecnÁ, Marie
  • Analytical Sciences, Vol. 26, Issue 9
  • DOI: 10.2116/analsci.26.989

Production of Outer Membrane Vesicles and Outer Membrane Tubes by Francisella novicida
journal, December 2012

  • McCaig, W. D.; Koller, A.; Thanassi, D. G.
  • Journal of Bacteriology, Vol. 195, Issue 6
  • DOI: 10.1128/JB.02007-12

Preparation, characterization, and immunogenicity of Haemophilus influenzae type b polysaccharide-protein conjugates
journal, August 1980


Humoral and cell-mediated immunity to the intracellular pathogen Francisella tularensis
journal, October 2008


Type A Francisella tularensis Acid Phosphatases Contribute to Pathogenesis
journal, February 2013


The complete genome sequence of Francisella tularensis, the causative agent of tularemia
journal, January 2005

  • Larsson, Pär; Oyston, Petra C. F.; Chain, Patrick
  • Nature Genetics, Vol. 37, Issue 2
  • DOI: 10.1038/ng1499

Identification of Francisella tularensis outer membrane protein A (FopA) as a protective antigen for tularemia
journal, July 2011


Uncovering the components of the Francisella tularensis virulence stealth strategy
journal, March 2014

  • Jones, Bradley D.; Faron, Matthew; Rasmussen, Jed A.
  • Frontiers in Cellular and Infection Microbiology, Vol. 4
  • DOI: 10.3389/fcimb.2014.00032

Host-Adaptation of Francisella tularensis Alters the Bacterium's Surface-Carbohydrates to Hinder Effectors of Innate and Adaptive Immunity
journal, July 2011


Live Attenuated Mutants of Francisella tularensis Protect Rabbits against Aerosol Challenge with a Virulent Type A Strain
journal, March 2014

  • Reed, Douglas S.; Smith, Le'Kneitah P.; Cole, Kelly Stefano
  • Infection and Immunity, Vol. 82, Issue 5
  • DOI: 10.1128/IAI.01498-14

Characterization of Outer Membrane Vesicles from Brucella melitensis and Protection Induced in Mice
journal, January 2012

  • Avila-Calderón, Eric Daniel; Lopez-Merino, Ahidé; Jain, Neeta
  • Clinical and Developmental Immunology, Vol. 2012
  • DOI: 10.1155/2012/352493

A Francisella tularensis Pathogenicity Island Required for Intramacrophage Growth
journal, September 2004


Tularemia in the United States: Epidemiologic Aspects in the 1960s and Follow-up of the Outbreak of Tularemia in Vermont
journal, March 1970


Identification of an Essential Francisella tularensis subsp. tularensis Virulence Factor
journal, November 2008

  • Qin, A.; Scott, D. W.; Thompson, J. A.
  • Infection and Immunity, Vol. 77, Issue 1
  • DOI: 10.1128/IAI.01113-08

Attenuation and protective efficacy of an O-antigen-deficient mutant of Francisella tularensis LVS
journal, September 2007


Phase separation of integral membrane proteins in Triton X-114 solution.
journal, February 1981


Proteomic Characterization and Functional Analysis of Outer Membrane Vesicles of Francisella novicida Suggests Possible Role in Virulence and Use as a Vaccine
journal, March 2011

  • Pierson, Tony; Matrakas, Demetrios; Taylor, Yuka U.
  • Journal of Proteome Research, Vol. 10, Issue 3
  • DOI: 10.1021/pr1009756

Tularemia Vaccine Study: II. Respiratory Challenge
journal, May 1961


Francisella tularensis Schu S4 O-Antigen and Capsule Biosynthesis Gene Mutants Induce Early Cell Death in Human Macrophages
journal, November 2010

  • Lindemann, Stephen R.; Peng, Kaitian; Long, Matthew E.
  • Infection and Immunity, Vol. 79, Issue 2
  • DOI: 10.1128/IAI.00863-10

Multimethodological Approach to Identification of Glycoproteins from the Proteome of Francisella tularensis , an Intracellular Microorganism
journal, April 2010

  • Balonova, Lucie; Hernychova, Lenka; Mann, Benjamin F.
  • Journal of Proteome Research, Vol. 9, Issue 4
  • DOI: 10.1021/pr9011602

Inhibition of AcpA Phosphatase Activity with Ascorbate Attenuates Francisella tularensis Intramacrophage Survival
journal, December 2009

  • McRae, Steven; Pagliai, Fernando A.; Mohapatra, Nrusingh P.
  • Journal of Biological Chemistry, Vol. 285, Issue 8
  • DOI: 10.1074/jbc.M109.039511

Aerosol Infection of man with Pasteurella Tularensis
journal, January 1961


Characterization of a Wild-Type Strain of Francisella Tularensis Isolated from a Cat
journal, September 2004

  • Inzana, Thomas J.; Glindemann, Gretchen E.; Snider, Gerald
  • Journal of Veterinary Diagnostic Investigation, Vol. 16, Issue 5
  • DOI: 10.1177/104063870401600502

Innate and Adaptive Immunity to Francisella
journal, March 2007

  • Elkins, K. L.; Cowley, S. C.; Bosio, C. M.
  • Annals of the New York Academy of Sciences, Vol. 1105, Issue 1
  • DOI: 10.1196/annals.1409.014

Tularemia Outbreak, Bulgaria, 1997–2005
journal, April 2006

  • Kantardjiev, Todor; Ivanov, Ivan; Velinov, Tzvetan
  • Emerging Infectious Diseases, Vol. 12, Issue 4
  • DOI: 10.3201/eid1204.050709

Tularemia as a Biological Weapon: Medical and Public Health Management
journal, June 2001


Identification, Characterization and Immunogenicity of an O-Antigen Capsular Polysaccharide of Francisella tularensis
journal, July 2010


Tularemia vaccine development: paralysis or progress?
journal, May 2016

  • Sunagar, Raju; Kumar, Sudeep; Franz, Brian
  • Vaccine: Development and Therapy
  • DOI: 10.2147/VDT.S85545

Determination of Dextran with Anthrone
journal, November 1953


Purification of outer membrane vesicles from Pseudomonas aeruginosa and their activation of an IL-8 response
journal, August 2006


Molecular Epidemiology, Evolution, and Ecology of Francisella
journal, March 2007

  • Keim, P.; Johansson, A.; Wagner, D. M.
  • Annals of the New York Academy of Sciences, Vol. 1105, Issue 1
  • DOI: 10.1196/annals.1409.011

Native Outer Membrane Proteins Protect Mice against Pulmonary Challenge with Virulent Type A Francisella tularensis
journal, May 2008

  • Huntley, J. F.; Conley, P. G.; Rasko, D. A.
  • Infection and Immunity, Vol. 76, Issue 8
  • DOI: 10.1128/IAI.00374-08

Glycosylation of a Capsule-Like Complex (CLC) by Francisella novicida Is Required for Virulence and Partial Protective Immunity in Mice
journal, May 2017

  • Freudenberger Catanzaro, Kelly C.; Champion, Anna E.; Mohapatra, Nrusingh
  • Frontiers in Microbiology, Vol. 8
  • DOI: 10.3389/fmicb.2017.00935

Protection afforded against aerosol challenge by systemic immunisation with inactivated Francisella tularensis live vaccine strain (LVS)
journal, February 2008


Polar Glycosylated and Lateral Non-Glycosylated Flagella from Aeromonas hydrophila Strain AH-1 (Serotype O11)
journal, November 2015

  • Fulton, Kelly; Mendoza-Barberá, Elena; Twine, Susan
  • International Journal of Molecular Sciences, Vol. 16, Issue 12
  • DOI: 10.3390/ijms161226097

Glycosylation of DsbA in Francisella tularensis subsp. tularensis
journal, July 2011

  • Thomas, R. M.; Twine, S. M.; Fulton, K. M.
  • Journal of Bacteriology, Vol. 193, Issue 19
  • DOI: 10.1128/JB.00438-11

Phenotypic characterization of the Francisella tularensis ΔpdpC and ΔiglG mutants
journal, December 2016


Tularemia: History, Epidemiology, Pathogen Physiology, and Clinical Manifestations
journal, March 2007


Francisella tularensis: unravelling the secrets of an intracellular pathogen
journal, August 2008


Protection Afforded by Heat Shock Protein 60 from Francisella tularensis Is Due to Copurified Lipopolysaccharide
journal, June 2004


Role of the wbt Locus of Francisella tularensis in Lipopolysaccharide O-Antigen Biogenesis and Pathogenicity
journal, October 2006

  • Raynaud, C.; Meibom, K. L.; Lety, M. -A.
  • Infection and Immunity, Vol. 75, Issue 1
  • DOI: 10.1128/IAI.01429-06

Comparative proteomic profiling of culture filtrate proteins of less and highly virulent Francisella tularensis strains
journal, November 2010

  • Konecna, Klara; Hernychova, Lenka; Reichelova, Marketa
  • PROTEOMICS, Vol. 10, Issue 24
  • DOI: 10.1002/pmic.201000248

Genomic Comparison between a Virulent Type A1 Strain of Francisella tularensis and Its Attenuated O-Antigen Mutant
journal, April 2012

  • Modise, T.; Ryder, C.; Mane, S. P.
  • Journal of Bacteriology, Vol. 194, Issue 10
  • DOI: 10.1128/JB.00152-12

Isolation and characterization of platelet glycoprotein IV (CD36)
journal, May 1989


An Attenuated Strain of the Facultative Intracellular Bacterium Francisella tularensis Can Escape the Phagosome of Monocytic Cells
journal, September 2003


Loops and networks in control of Francisella tularensis virulence
journal, August 2009

  • Meibom, Karin L.; Barel, Monique; Charbit, Alain
  • Future Microbiology, Vol. 4, Issue 6
  • DOI: 10.2217/fmb.09.37